Skip to main content
Erschienen in: Pediatric Rheumatology 1/2021

Open Access 01.12.2021 | Case Report

Tibia stress injury and the imaging appearance of stress fracture in juvenile dermatomyositis: six patients’ experiences

verfasst von: Tomo Nozawa, Audrey Bell-Peter, Andrea S. Doria, Jo-Anne Marcuz, Jennifer Stimec, Kristi Whitney, Brian M. Feldman

Erschienen in: Pediatric Rheumatology | Ausgabe 1/2021

Abstract

Background

Tibial stress injuries are frequent injuries of the lower extremity and the most common causes of exercise-induced leg pain among athletes and military recruits. They sometimes occur in patients with pathological conditions of bone metabolism such as osteoporosis or rheumatoid arthritis, but there are previously no cases reported in juvenile dermatomyositis (JDM). Here we report 6 JDM patients who presented with shin pain, and the imaging appearance of tibial stress fractures or stress reactions.

Case presentation

All 6 patients with JDM presented with shin pain or tenderness in the anterior tibia without any evidence of excessive exercise or traumatic episode. They were diagnosed with tibial stress injuries based on a combination of radiographs, three-phase bone scans, and magnetic resonance imaging (MRI), and 5 out of 6 patients had been treated with prednisone and/or methotrexate at onset of tibial stress injuries. In one patient, we could not find any abnormalities in his radiograph, but the subsequent MRI showed tibial stress reaction. In all 6 patients, the tibial stress injuries improved with only rest and/or analgesics.

Conclusion

We experienced 6 children with JDM who presented with shin pain, and who were diagnosed with tibial stress fractures or stress reactions. Their underlying disease and weakness, treatment with glucocorticoid and methotrexate, or inactivity may have resulted in these tibial injuries, and made these patients more predisposed than other children. In addition to preventing JDM patients from getting osteoporosis, we need to consider stress reactions when children with JDM complain of sudden shin pain.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
BMD
Bone mineral density
DEXA
Dual energy X-ray absorptiometry
JDM
Juvenile dermatomyositis
MRI
Magnetic resonance imaging
MTX
Methotrexate

Background

Juvenile dermatomyositis (JDM) is a rare chronic inflammatory disease of childhood, characterized by skin involvement and proximal muscle weakness.
When JDM patients complain of pain in the lower extremities, pediatric rheumatologists may initially consider this to be an exacerbation of myositis. However, when leg pain – especially shin pain – appears, there are some differential diagnoses in addition to myositis. For example, tibial stress fractures and stress reactions – also known as “shin splints” – should be considered as one of the differential diagnoses. Generally, stress fractures are common in athletes and military recruits, and the most common location of stress fracture in the general population is the tibia [1]. This is also found to be the most common location among older children, in whom the most prevalent site is the proximal tibia [24]. Besides athletes, some reports describe stress fractures occurring in patients with pathological conditions of bone metabolism such as osteoporosis, or in rheumatoid arthritis [5]. However, there are no cases reported in the literature of this occurring in JDM. Here we report 6 JDM patients who presented with shin pain, and the imaging appearance of tibial stress fractures or stress reactions.

Case presentation

Table 1 shows the clinical features of 6 JDM patients who were diagnosed with tibial stress fractures or stress reactions. All imaging of those patients was reviewed by 2 radiologists, based on the Fredericson classification system [6]. Stress fracture was diagnosed by sclerosis, periosteal reaction/elevation, cortical thickening/or a fracture line at the site of pain. Stress reaction was defined as findings of bone marrow edema at a symptomatic site with no definite fracture on radiography or MRI [7].
Table 1
Main clinical features of the 6 patients
 
Case 1
Case 2
Case 3
Case 4
Case 5
Case 6
Sex
Female
Female
Male
Male
Male
Female
Age at stress reaction/stress fracture (years)
10
5
9
4
5
11
Months since diagnosis of JDM (months)
3
Prior to JDM diagnosis
7
18
9
20
Symptoms
Right lower leg pain
Tenderness over the right shin
Bilateral knee pain
Right shin pain
Bilateral shin pain
Right shin pain
Stress reaction or stress fracture
Stress fracture
Stress fracture
Stress reaction
Stress reaction
Stress reaction
Stress fracture
Location of stress reaction/stress fracture
Middle and lower third of right tibia, right proximal fibula
Bilateral proximal tibiae
Middle third
of bilateral tibiae
Middle diaphysis of the right tibia
Bilateral anterior cortical tibiae
Middle diaphysis of the right tibia
JDM therapy at stress reaction/stress fracture
Prednisone 1.2 mg/kg/day
No treatment
Prednisone 0.6 mg/kg/day, MTX
MTX
MTX
MTX
Interventions for stress injury/stress fracture
Rest and analgesics
Rest
Rest
Rest
Rest
Rest
Physical function before tibial lesion
Limitation of extracurricular activities only
Limitation of instrumental daily activities
No limited activities
No limited activities
Limitation of extracurricular activities only
No limited activities
Muscle weakness in lower extremities at time of tibial lesion
No
Yes
No
No
Yes
No
Modified disease activity score at stress reaction/stress fracture (0–11)
2
Not evaluated
1
1
3
3
Age matched BMD
Normal range
Normal range
Normal range
Not evaluated
Normal range
Normal range
Regional osteoporosis or osteopenia
No
No
No
Osteopenia
No
No
Serum 25-hydroxyvitamin D prior to stress reaction/stress fracture, nmol/L
65
Not measured
19
113
100
45
Modified disease activity score includes clinical parameters for three dermatological (0–4 points) and three musculoskeletal criteria (0–7 points) [24]. BMD Bone mineral density, JDM Juvenile dermatomyositis, MTX Methotrexate

Case 1

This girl was diagnosed at the age of 9 with JDM based on proximal muscle weakness, arthritis, and the appearance of a heliotrope rash and Gottron papules. After making a diagnosis, she was started on prednisone at a dose of 2 mg/kg/day. She showed significant improvement in her symptoms, except for persistent skin manifestations. Her prednisone was gradually tapered. Three months later, right lower shin pain suddenly appeared without any evidence of excessive exercise or traumatic episode. She presented for evaluation 3 days later at which time she had only right lower shin pain and no other abnormal symptoms or signs. A radiograph performed at another hospital revealed a horizontal line at the junction of the middle and lower thirds of the right tibia, consistent with a stress fracture. One week later, on radiographic re-examination and three-phase bone scan, an undisplaced fracture at the right proximal fibula was revealed. Her right lower shin pain improved with conservative management of short-term rest and analgesics by 2 months. Bone mineral density (BMD), by dual energy X-ray absorptiometry (DEXA) of both the regional bone and the lumbar spine (83 % of age-matched BMD) was in the normal range.

Case 2

This 5 year-old girl had some tenderness, lasting for 2 weeks, in the anterior right tibia 4 months before a diagnosis of JDM was made, based on rash and muscle weakness with an abnormal muscle biopsy. She had never previously received any treatment with glucocorticoids or disease-modifying anti-rheumatic drugs. At the same time as she developed tenderness in her right tibia, she also presented with fatigue, anorexia, and diffuse joint and muscle pains. At the time of evaluation for JDM, a radiograph and three-phase bone scan were performed looking for the cause of her tibial tenderness. The radiograph of her right tibia revealed thickening of the anterior cortex of the mid tibia. Furthermore, the three-phase bone scan showed a focal linear increased uptake along the lateral cortex of the proximal tibia bilaterally. There was no evidence of any soft tissue uptake. The findings of the radiograph and three-phase bone scan were consistent with stress fractures of both tibiae. When she was transferred to our hospital six months later, the fractures had already healed without additional treatment. A BMD scan looking at regional bone and both femoral necks was normal at the time of transferring her care to our hospital.

Case 3

This boy was diagnosed with JDM on magnetic resonance imaging (MRI) at the age of 9 when he presented with polyarthralgia, vasculopathic rash and proximal muscle weakness. He was initially treated with prednisone at a dose of 1 mg/kg/day and methotrexate (MTX). With this treatment, his symptoms associated with JDM improved significantly. As a result, he was able to gradually taper his prednisone without JDM flare. Six months after diagnosis, severe bilateral shin pain lasting for 2 weeks appeared suddenly without muscle weakness and joint involvement. Although he was regularly playing basketball – due to increased physical functional capacity – before the pain episode, he had no recalled trauma. The physical examination revealed mild tenderness over both of his shins. Radiographs, an MRI and a three-phase bone scan were performed. The radiographs showed no evidence of fracture or periosteal reaction in the tibia or fibula, but the subsequent MRI showed bilateral periosteal thickening, and increased T2 signal intensity within the bone marrow and anterior soft tissues of the middle third of both tibias (Fig. 1). In addition, the three-phase bone scan revealed bilateral symmetric linear increased activity that was noted in the anterior tibial cortices on blood pool and (more intensely) on delayed images. These findings were consistent with a tibial stress reaction. His shin pain improved without analgesics over several months. A BMD of the regional bone was normal, and BMD in the lumbar spine and femur was normal (96 % and 92 % of age matched BMD values, respectively).

Case 4

This boy was diagnosed with JDM at the age of 3 based on Gottron papules, polyarthritis, muscle weakness with elevated creatinine kinase, and MRI abnormalities indicating myositis. He was initially treated with prednisone at a dose of 2 mg/kg/day and MTX. With this treatment his symptoms improved, except for mild persistent skin manifestations; he was able to discontinue prednisone 10 months after starting treatment. Five months later, he developed right shin pain lasting for 2 weeks, that suddenly started without any recalled trauma. He had tenderness, swelling and warmth over the right tibia. Radiographs demonstrated linear subperiosteal new bone formation adjacent to the middle diaphysis with decreased bone density (Fig. 2). Further evaluation by MRI showed periosteal reaction with edematous changes in his right tibia without a discrete fracture line, and without worsening inflammation of the surrounding muscles (Fig. 2). His findings were consistent with a tibial stress reaction. His shin pain improved without analgesics after about 5 months. He did not have BMD evaluation by DEXA during his investigation in our institution.

Case 5

This boy was diagnosed with JDM at the age of 4 based on Gottron papules, heliotrope rash, and proximal muscle weakness with MRI findings. He was initially treated with prednisone at a dose of 2 mg/kg/day and MTX. His JDM activity remained controlled during tapering of his prednisone and he was able to discontinue his prednisone 8 months after starting. One month later, he developed bilateral shin pain, lasting for 3 weeks, that was associated with restriction in his exercise capacity and interference with sleep. He recalled no traumatic episodes. The physical examination found point tenderness in the mid one-third of the left tibia. Radiographs and MRI showed thickening / periosteal reaction noted at the anterior cortex of the bilateral tibias, consistent with a tibial stress reaction. There was minimal bone marrow edema at the anterior part of the bones, but no associated myositis or obvious fracture. Five months later, his shin pain resolved with conservative measures and rest. A BMD of the regional bone and the lumbar spine (92 % of age matched BMD values) was normal.

Case 6

This girl was diagnosed with JDM at the age of 9 based on Gottron papules, heliotrope rash, and proximal muscle weakness, with elevated creatinine kinase and typical MRI findings. She was initially treated with prednisone at a dose of 2 mg/kg/day and MTX. She responded well and was able to discontinue prednisone 1 year after starting. Seven months later, she developed right shin pain, lasting for about 5 weeks, that appeared without any trauma. Due to increasing pain, radiographs were performed, followed by a subsequent MRI scan. Her radiographs were suggestive of a previous stress injury in the mid tibial diaphysis. The MRI examination showed altered marrow signal within the right tibia, demonstrating T1 hypointensity and T2 hyperintensity, consistent with a stress fracture (Fig. 3). The follow-up lateral radiograph which was obtained 3 months after the initial X-ray showed persistence of a focal area of sclerosis, increased in extent compared to previous (Fig. 4). However, the shin pain gradually improved within 6 months, and a follow-up MRI examination which was performed almost 1 year after the initial X-ray showed improvement of the altered marrow signal (Fig. 4). BMD of the regional bone and lumbar spine (84 % of age matched BMD values) was normal.

Discussion and conclusions

Stress fractures in prepubescent children who don’t vigorously participate in sport activities appear to be very uncommon. In the pediatric age group, there are only a few case reports and small series, mostly of child athletes. In a large population-based study, it was reported that 3.9 % of adolescent girls, aged 9 to 15 years, developed a stress fracture during a 7-year period, and that these stress fractures were related to participating in running, basketball, cheerleading, and gymnastics [8].
As our case series is retrospective, it is unclear whether children with JDM are more susceptible to tibial stress fractures and tibial stress reactions compared to healthy children. However, tibial stress fractures and tibial stress reactions developed in 6 of 189 patients (3.2 %) who were followed in our inception cohort and met the 2017 EULAR/ACR classification criteria [9]; while this frequency is similar to that reported by Field et al. [8], our patients were mostly not athletic at the time of injury, being in the recovery phase of myositis.
It may be that JDM poses additional risks for tibial stress fractures / stress reactions. First, stress fractures appear to occur because of repetitive muscular forces or stresses applied to a bone. Previous papers have reported muscle imbalance and inflexibility, especially tightness of the triceps surae (soleus, gastrocnemius, and plantaris muscles), as being commonly associated with tibial stress reactions [10]. For example, athletes with muscle weakness of the triceps surae tend to develop muscle fatigue, leading to altered running mechanics, and strain on the tibia. Also, weakness of the core muscles is reported to be an important risk factor for lower extremity injuries. Hip and pelvis muscle strength are an important link in maintaining control and proper mechanics between the core and lower extremity. Children with JDM who have muscle weakness or insufficient muscle endurance may, therefore, be predisposed to develop tibial stress reactions. Second, glucocorticoid and/or MTX treatment has been suggested as a possible cause for stress fractures and stress reactions in the tibia [1115]. Both medications are commonly known to induce reduced bone density. MTX can cause osteopathy in two ways; MTX increases urinary and fecal excretion of calcium and enhances osteoclastic bone resorption [16]. A study of MTX given to rats over the short-term demonstrated toxic effects on osteoblasts, with a 60 % reduction on the rate of bone formation, resulting in decreased osteoid volume and thickness [17]. In previous reports that have described tibial stress reactions in patients with rheumatoid arthritis and psoriasis, those patients were treated with methotrexate and/or glucocorticoid [13, 18]. Radiographs of the lesions in those patients demonstrated osteopenia, or osteoporosis, with the stress reactions. Only one of our patients (Case 4) had demonstrable regional osteopenia. Although withdrawal of MTX is the suggested choice when dealing with MTX osteopathy, our two JDM patients’ complications healed without stopping MTX. Except for Case 2 who had stress fractures before a diagnosis of JDM, 5 patients had received calcium and vitamin D supplementation to avoid osteoporosis since their diagnosis of JDM. Therefore, as shown in Table 1, the levels of serum 25-hydroxyvitamin D prior to stress reaction/stress fracture in 3 of 5 patients were within normal range (> 50 nmol/L). According to international guidelines, for glucocorticoid-treated children, calcium and vitamin D intake is recommended to avoid osteoporosis [19]. As a preventive strategy for stress fracture, a routine DEXA is reported to be very important in addition to calcium and vitamin D supplementation [20].
It would seem to be important to properly diagnose tibial stress fractures and stress reactions, both to rule out more sinister causes, but also because these stress fractures are sometimes a cause of disordered bone growth [10, 21]. The diagnosis requires a high level of clinical suspicion, based on focal tenderness of the tibia, and confirmation is needed with imaging [22]. Radiographs are sometimes normal until 3 weeks to 3 months after the onset of pain. We could not make the diagnosis of a stress fracture in one patient of our cohort (Case 3) when considering the initial radiograph solely. If the initial radiographs are normal but there is persistent clinical concern, MRI or three-phase bone scan should be considered for further diagnosis.
The most important management of tibial stress fracture and stress reaction is to reduce impact loading until the pain resolves. Even after these injuries resolve, though, care must be taken to detect the appearance of new lower extremity symptoms because of a high reported recurrence rate [23].
In conclusion, we have reported the cases of 6 children with JDM who presented with shin pain, and who were diagnosed with tibial stress fractures or stress reactions. Their underlying disease and weakness, treatment with glucocorticoid and MTX, or inactivity may have resulted in these tibial injuries, and made these patients more predisposed than other children. It would appear to be reasonable to follow international guidelines to avoid osteoporosis, in part to avoid these injuries [19]. Furthermore, we need to consider stress reactions when children with JDM complain of sudden shin pain.

Acknowledgements

Not Applicable.
Not Applicable.
Not Applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Iwamoto J, Takeda T. Stress fractures in athletes: review of 196 cases. J Orthop Sci. 2003;8:273–8.CrossRef Iwamoto J, Takeda T. Stress fractures in athletes: review of 196 cases. J Orthop Sci. 2003;8:273–8.CrossRef
2.
Zurück zum Zitat Dixon S, Newton J, Teh J. Stress fractures in the young athlete: a pictorial review. Curr Probl Diagn Radiol. 2011;40:29–44.CrossRef Dixon S, Newton J, Teh J. Stress fractures in the young athlete: a pictorial review. Curr Probl Diagn Radiol. 2011;40:29–44.CrossRef
3.
Zurück zum Zitat Devas MB. Stress fractures in children. J Bone Joint Surg Br. 1963;45:528–41.CrossRef Devas MB. Stress fractures in children. J Bone Joint Surg Br. 1963;45:528–41.CrossRef
4.
Zurück zum Zitat Keret D, Segev E, Hayek S, Lokiec F, Wientroub S. Bilateral symmetric stress fractures in a toddler. J Pediatr Orthop B. 2001;10:73–7.PubMed Keret D, Segev E, Hayek S, Lokiec F, Wientroub S. Bilateral symmetric stress fractures in a toddler. J Pediatr Orthop B. 2001;10:73–7.PubMed
5.
Zurück zum Zitat Lingg GM, Soltèsz I, Kessler S, Dreher R. Insufficiency and stress fractures of the long bones occurring in patients with rheumatoid arthritis and other inflammatory diseases, with a contribution on the possibilities of computed tomography. Eur J Radiol. 1997;26:54–63.CrossRef Lingg GM, Soltèsz I, Kessler S, Dreher R. Insufficiency and stress fractures of the long bones occurring in patients with rheumatoid arthritis and other inflammatory diseases, with a contribution on the possibilities of computed tomography. Eur J Radiol. 1997;26:54–63.CrossRef
6.
Zurück zum Zitat Fredericson M, Bergman AG, Hoffman KL, Dillingham MS. Tibial stress reaction in runners. Correlation of clinical symptoms and scintigraphy with a new magnetic resonance imaging grading system. Am J Sports Med. 1995;23:472–81.CrossRef Fredericson M, Bergman AG, Hoffman KL, Dillingham MS. Tibial stress reaction in runners. Correlation of clinical symptoms and scintigraphy with a new magnetic resonance imaging grading system. Am J Sports Med. 1995;23:472–81.CrossRef
7.
Zurück zum Zitat Hayashi D, Jarraya M, Engebretsen L, D Crema M, Roemer W, Skaf F. A, et al. Epidemiology of imaging-detected bone stress injuries in athletes participating in the Rio de Janeiro 2016 Summer Olympics. Br J Sports Med. 2018;52:465–9. Hayashi D, Jarraya M, Engebretsen L, D Crema M, Roemer W, Skaf F. A, et al. Epidemiology of imaging-detected bone stress injuries in athletes participating in the Rio de Janeiro 2016 Summer Olympics. Br J Sports Med. 2018;52:465–9.
8.
Zurück zum Zitat Field AE, Gordon CM, Pierce LM, Ramappa A, Kocher MS. Prospective study of physical activity and risk of developing a stress fracture among preadolescent and adolescent girls. Arch Pediatr Adolesc Med. 2011;165:723–8.CrossRef Field AE, Gordon CM, Pierce LM, Ramappa A, Kocher MS. Prospective study of physical activity and risk of developing a stress fracture among preadolescent and adolescent girls. Arch Pediatr Adolesc Med. 2011;165:723–8.CrossRef
9.
Zurück zum Zitat Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, Visser M, et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76:1955–64.CrossRef Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, Visser M, et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76:1955–64.CrossRef
10.
Zurück zum Zitat Galbraith RM, Lavallee ME. Medial tibial stress syndrome: conservative treatment options. Curr Rev Musculoskelet Med. 2009;2:127–33.CrossRef Galbraith RM, Lavallee ME. Medial tibial stress syndrome: conservative treatment options. Curr Rev Musculoskelet Med. 2009;2:127–33.CrossRef
11.
Zurück zum Zitat Kuemmerle-Deschner JB, Dammann F, Niethammer D, Dannecker GE. Stress fractures: diagnostic pitfalls in juvenile idiopathic arthritis. Rheumatology. 2001;40:1313–4.CrossRef Kuemmerle-Deschner JB, Dammann F, Niethammer D, Dannecker GE. Stress fractures: diagnostic pitfalls in juvenile idiopathic arthritis. Rheumatology. 2001;40:1313–4.CrossRef
12.
Zurück zum Zitat Huber AM, Ward LM. The impact of underlying disease on fracture risk and bone mineral density in children with rheumatic disorders: A review of current literature. Semin Arthritis Rheum. 2016;46:49–63.CrossRef Huber AM, Ward LM. The impact of underlying disease on fracture risk and bone mineral density in children with rheumatic disorders: A review of current literature. Semin Arthritis Rheum. 2016;46:49–63.CrossRef
13.
Zurück zum Zitat Zonneveld IM, Bakker WK, Dijkstra PF, Bos JD, van Soesbergen RM, Dinant HJ. Methotrexate osteopathy in long-term, low-dose methotrexate treatment for psoriasis and rheumatoid arthritis. Arch Dermatol. 1996;132:184–7.CrossRef Zonneveld IM, Bakker WK, Dijkstra PF, Bos JD, van Soesbergen RM, Dinant HJ. Methotrexate osteopathy in long-term, low-dose methotrexate treatment for psoriasis and rheumatoid arthritis. Arch Dermatol. 1996;132:184–7.CrossRef
14.
Zurück zum Zitat Tan T, Ho W. Sequential Proximal Tibial Stress Fractures associated with Prolonged usage of Methotrexate and Corticosteroids: A Case Report. Malays Orthop J. 2015;9:65–7.CrossRef Tan T, Ho W. Sequential Proximal Tibial Stress Fractures associated with Prolonged usage of Methotrexate and Corticosteroids: A Case Report. Malays Orthop J. 2015;9:65–7.CrossRef
15.
Zurück zum Zitat Stevens H, Jacobs JW, Van Rijk PP, De Klerk JM. Methotrexate osteopathy demonstrated by Technetium-99m HDP bone scintigraphy. Clin Nucl Med. 2001;26:389–91.CrossRef Stevens H, Jacobs JW, Van Rijk PP, De Klerk JM. Methotrexate osteopathy demonstrated by Technetium-99m HDP bone scintigraphy. Clin Nucl Med. 2001;26:389–91.CrossRef
16.
Zurück zum Zitat Preston SJ, Diamond T, Scott A, Laurent MR. Methotrexate osteopathy in rheumatic disease. Ann Rheum Dis. 1993;52:582–5.CrossRef Preston SJ, Diamond T, Scott A, Laurent MR. Methotrexate osteopathy in rheumatic disease. Ann Rheum Dis. 1993;52:582–5.CrossRef
17.
Zurück zum Zitat Friedlaender GE, Tross RB, Doganis AC, Kirkwood JM, Baron R. Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model. J Bone Joint Surg Am. 1984;66:602–7.CrossRef Friedlaender GE, Tross RB, Doganis AC, Kirkwood JM, Baron R. Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model. J Bone Joint Surg Am. 1984;66:602–7.CrossRef
18.
Zurück zum Zitat Cimşit C, Buğdayci O, Aribal ME. Osteopathic Potential of Methotrexate: Medial Tibial Stress Syndrome. Arch Rheumatol. 2016;31:386–7.CrossRef Cimşit C, Buğdayci O, Aribal ME. Osteopathic Potential of Methotrexate: Medial Tibial Stress Syndrome. Arch Rheumatol. 2016;31:386–7.CrossRef
19.
Zurück zum Zitat Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE, et al. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Rheumatol. 2017;69:1521–37.CrossRef Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE, et al. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Rheumatol. 2017;69:1521–37.CrossRef
20.
Zurück zum Zitat Chen YT, Tenforde AS, Fredericson M. Update on stress fractures in female athletes: epidemiology, treatment, and prevention. Curr Rev Musculoskelet Med. 2013;6:173–81.CrossRef Chen YT, Tenforde AS, Fredericson M. Update on stress fractures in female athletes: epidemiology, treatment, and prevention. Curr Rev Musculoskelet Med. 2013;6:173–81.CrossRef
21.
Zurück zum Zitat Lynch KR, Kemper HCG, Turi-Lynch B, Agostinete RR, Ito IH, Luiz-De-Marco R, et al. Impact sports and bone fractures among adolescents. J Sports Sci. 2017;35:2421–6.CrossRef Lynch KR, Kemper HCG, Turi-Lynch B, Agostinete RR, Ito IH, Luiz-De-Marco R, et al. Impact sports and bone fractures among adolescents. J Sports Sci. 2017;35:2421–6.CrossRef
23.
Zurück zum Zitat Yates B, White S. The incidence and risk factors in the development of medial tibial stress syndrome among naval recruits. Am J Sports Med. 2004;32:772–80.CrossRef Yates B, White S. The incidence and risk factors in the development of medial tibial stress syndrome among naval recruits. Am J Sports Med. 2004;32:772–80.CrossRef
Metadaten
Titel
Tibia stress injury and the imaging appearance of stress fracture in juvenile dermatomyositis: six patients’ experiences
verfasst von
Tomo Nozawa
Audrey Bell-Peter
Andrea S. Doria
Jo-Anne Marcuz
Jennifer Stimec
Kristi Whitney
Brian M. Feldman
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
Pediatric Rheumatology / Ausgabe 1/2021
Elektronische ISSN: 1546-0096
DOI
https://doi.org/10.1186/s12969-021-00501-9

Weitere Artikel der Ausgabe 1/2021

Pediatric Rheumatology 1/2021 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.